Summers Shaun A, Steinmetz Oliver M, Li Ming, Kausman Joshua Y, Semple Timothy, Edgtton Kristy L, Borza Dorin-Bogdan, Braley Hal, Holdsworth Stephen R, Kitching A Richard
Centre for Inflammatory Diseases, Monash University Department of Medicine, Monash Medical Centre, 246 Clayton Road, Clayton, Victoria 3168, Australia.
J Am Soc Nephrol. 2009 Dec;20(12):2518-24. doi: 10.1681/ASN.2009030337. Epub 2009 Oct 9.
Th1 effector CD4+ cells contribute to the pathogenesis of proliferative and crescentic glomerulonephritis, but whether effector Th17 cells also contribute is unknown. We compared the involvement of Th1 and Th17 cells in a mouse model of antigen-specific glomerulonephritis in which effector CD4+ cells are the only components of adaptive immunity that induce injury. We planted the antigen ovalbumin on the glomerular basement membrane of Rag1(-/-) mice using an ovalbumin-conjugated non-nephritogenic IgG1 monoclonal antibody against alpha3(IV) collagen. Subsequent injection of either Th1- or Th17-polarized ovalbumin-specific CD4+ effector cells induced proliferative glomerulonephritis. Mice injected with Th1 cells developed progressive albuminuria over 21 d, histologic injury including 5.5 +/- 0.9% crescent formation/segmental necrosis, elevated urinary nitrate, and increased renal NOS2, CCL2, and CCL5 mRNA. Mice injected with Th17 cells developed albuminuria by 3 d; compared with Th1-injected mice, their glomeruli contained more neutrophils and greater expression of renal CXCL1 mRNA. In conclusion, Th1 and Th17 effector cells can induce glomerular injury. Understanding how these two subsets mediate proliferative forms of glomerulonephritis may lead to targeted therapies.
辅助性T细胞1(Th1)效应性CD4+细胞参与增殖性和新月体性肾小球肾炎的发病机制,但效应性辅助性T细胞17(Th17)细胞是否也参与其中尚不清楚。我们在抗原特异性肾小球肾炎小鼠模型中比较了Th1和Th17细胞的参与情况,在该模型中,效应性CD4+细胞是诱导损伤的适应性免疫的唯一组成部分。我们使用抗α3(IV)胶原的卵清蛋白偶联的非致肾炎性IgG1单克隆抗体将抗原卵清蛋白植入Rag1(-/-)小鼠的肾小球基底膜上。随后注射Th1或Th17极化的卵清蛋白特异性CD4+效应细胞可诱导增殖性肾小球肾炎。注射Th1细胞的小鼠在21天内出现进行性蛋白尿,组织学损伤包括5.5±0.9%的新月体形成/节段性坏死,尿硝酸盐升高,以及肾NOS2、CCL2和CCL5 mRNA增加。注射Th17细胞的小鼠在3天时出现蛋白尿;与注射Th1的小鼠相比,它们的肾小球含有更多的中性粒细胞,肾CXCL1 mRNA表达更高。总之,Th1和Th17效应细胞均可诱导肾小球损伤。了解这两个亚群如何介导增殖性肾小球肾炎可能会带来靶向治疗方法。